Table of Contents
PMID: 27512487
Ondansetron, not approved for use in pregnancy, is increasingly being prescribed for nausea and vomiting in pregnancy and hyperemesis gravidarum
SOGC Clinical Practice Guideline | Volume 38, ISSUE 12, P1127
1 Despite lack of United States Food and Drug Administration approval for indicated use in pregnancy
Most research
For treatment of mild-to-moderate nausea and vomiting of pregnancy and hyperemesis gravidarum, the American College of Obstetricians and Gynecologists recommends
tired feeling
A number of recent lawsuits have highlighted the possibility that ondansetron may cause congenital malformations
To reduce the risk of dizziness Note: Sandoz Canada Inc only markets ZOFRAN ODT (ondansetron) as an orally disintegrating tablet
Zofran (ondansetron) is used to prevent nausea and vomiting caused by surgery or cancer medicines
Ondansetron is increasingly used off label to treat nausea and vomiting during pregnancy
Zofran (Ondansetron) belongs to the class of medications called 5-HT3 receptor antagonists
Question Je prescris habituellement de la doxylamine-pyridoxine pour la nausée matinale, mais certaines de mes patientes qui ont des problèmes sévères de nausées et de vomissements de la grossesse (NVG) reçoivent de l’ondansétron à l 2018 Jul;40 (7):910-918
10
But GlaxoSmithKline decided that Zofran would be a good medication for pregnant mothers who experience morning sickness also
9% are initially used in the first 3 months of pregnancy (van Gelder and Nordeng, 2021)
12 to 17 years of age: 8 mg administered 30 minutes before the start of chemotherapy, with a subsequent 8-mg dose 8 hours after the first dose
Diclectin is a drug authorized in Canada to treat nausea and vomiting in pregnancy (i
Ondansetron, sold under the brand name Zofran among others, is a medication used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, Pregnancy
This is a descriptive retrospective case series of 14 pregnant women treated with ondansetron for hyperemesis gravidarum (HG) at CHU Sainte-Justine, from January 2002 to October 2011
3 million pregnancies take Zofran during pregnancy
District Court, Eastern District of Pennsylvania 1
[1] In this paper, Colin Dormuth, a drug safety researcher at The University of British Columbia in Canada, and colleagues combined data from Canada, the United States, and the United Kingdom about pregnancy outcomes when the pregnant person took Zofran or another medication to prevent nausea and vomiting